Login
Population (July 2005)
26.4m
GDP (PPP data, 2004)
$310.2bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Size of pharmaceutical market (sales, 2001)
Percentage of GDP on pharmaceuticals (2002)
Percentage of health expenditure spent on medicines (2001)
Pharmaceutical market growth rate (2001)
Local currency
Saudi Riyal (SR)
Summary: Saudi Arabia
It is becoming increasingly clear that the Saudi government will not be able to face the growing demand for improved healthcare services required by a population set to reach 30m inhabitants by 2008. The authorities are considering reforming the pharmaceutical industry, and changing the existing rules of drug purchase and distribution. Private insurance is being made compulsory to foreign workers as a first step in a greater participation of the private sector in the implementation of the Kingdom’s national development program.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
11/12/2005
TRIPS to be endorsed as Saudis join WTO
04/09/2005
Saudi Arabia to build 250 additional hospitals
03/08/2005
Health insurance market to boom
Related Items